Bioethical issues in genome editing by CRISPR-Cas9 technology
Bioethical issues in genome editing by CRISPR-Cas9 technology
Genome editing technologies have led to fundamental changes in genetic science. Among them, CRISPR-Cas9 technologyparticularly stands out due to its advantages such as easy handling, high accuracy, and low cost. It has made a quick introduction infields related to humans, animals, and the environment, while raising difficult questions, applications, concerns, and bioethical issuesto be discussed. Most concerns stem from the use of CRISPR-Cas9 to genetically alter human germline cells and embryos (calledgermline genome editing). Germline genome editing leads to serial bioethical issues, such as the occurrence of undesirable changesin the genome, from whom and how informed consent is obtained, and the breeding of the human species (eugenics). However, thebioethical issues that CRISPR-Cas9 technology could cause in the environment, agriculture and livestock should also not be forgotten.In order for CRISPR-Cas9 to be used safely in all areas and to solve potential issues, worldwide legislation should be prepared, takinginto account the opinions of both life and social scientists, policy makers, and all other stakeholders of the sectors, and CRISPR-Cas9applications should be implemented according to such legislations. However, these controls should not restrict scientific freedom. Here,various applications of CRISPR-Cas9 technology, especially in medicine and agriculture, are described and ethical issues related togenome editing using CRISPR-Cas9 technology are discussed. The social and bioethical concerns in relation to human beings, otherorganisms, and the environment are addressed.
___
- Amoasii L, Hildyard JC, Li H, Sanchez-Ortiz E, Mireault A et al.
(2018). Gene editing restores dystrophin expression in a canine
model of Duchenne muscular dystrophy. Science 362 (6410):
86-91.
- Amoroso PJ, Wenger LL (2003). The human volunteer in military
biomedical research. In: Beam TE, Sparacino LR, Pellegrino
ED, Hartle AE, Howe EG (editors). Military Medical Ethics.
Volume 2. Washington, DC, USA: Walter Reed Army Medical
Center, pp. 563-660.
- Arévalo MT, Navarro A, Arico CD, Li J, Alkhatib O et al. (2014).
Targeted silencing of anthrax toxin receptors protects against
anthrax toxins. Journal of Biological Chemistry 289 (22):
15730-15738.
- Baltimore D, Berg P, Botchan M, Carroll D, Charo RA et al. (2015).
A prudent path forward for genomic engineering and germline
gene modification. Science 348 (6230): 36-38.
- Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P et al.
(2007). CRISPR provides acquired resistance against viruses in
prokaryotes. Science 315 (5819): 1709-1712.
- Beriain IDM, del Cano AMM (2018). Gene editing in human
embryos. A comment on the ethical issues involved. In:
Soniewicka M (editor). The Ethics of Reproductive Genetics.
Cham, Switzerland: Springer, pp. 173-187.
- Black CK, Termanini KM, Aguirre O, Hawksworth JS, Sosin M
(2018). Solid organ transplantation in the 21st century. Annals
of Translational Medicine 6 (20): 409.
- Brokowski C (2018). Do CRISPR germline ethics statements cut it?
CRISPR Journal 1 (2): 115-125.
- Cai L, Zheng LA, He L (2018). The forty years of medical genetics
in China. Journal of Genetics and Genomics 45 (11): 569-582.
- Carroll D (2017). Focus: Genome editing: genome editing: past,
present, and future. Yale Journal of Biology and Medicine 90
(4): 653.
- Cathomen T, Schüle S, Schüßler-Lenz M, Abou-El-Enein M (2019).
The human genome editing race: loosening regulatory
standards for commercial advantage? Trends in Biotechnology
37 (2): 120-123.
- Charlesworth CT, Deshpande PS, Dever DP, Camarena J, Lemgart VT
et al. (2019). Identification of preexisting adaptive immunity to
Cas9 proteins in humans. Nature Medicine 25 (2): 249.
- Chen H, Kazemier HG, de Groote ML, Ruiters MH, Xu GL et al.
(2013). Induced DNA demethylation by targeting ten-eleven
translocation 2 to the human ICAM-1 promoter. Nucleic Acids
Research 42 (3): 1563-1574.
- Chin A (2015). CRISPR-Cas9 Therapeutics: A Technology Overview.
Oxford, UK: Biostars.
- Collins FS (2015). Statement on NIH Funding of Research Using
Gene-Editing Technologies in Human Embryos. Bethesda, MD,
USA: National Institutes of Health.
- Cornelis MC, Nugent NR, Amstadter AB, Koenen KC (2010). Genetics
of post-traumatic stress disorder: review and recommendations
for genome-wide association studies. Current Psychiatry
Reports 12 (4): 313-326.
- Cyranoski D, Reardon S (2015). Chinese scientists genetically modify
human embryos. Nature News 346: 1258096.
- de Graeff N, Jongsma KR, Johnston J, Hartley S, Bredenoord AL
(2019). The ethics of genome editing in non-human animals: a
systematic review of reasons reported in the academic literature.
Philosophical Transactions of the Royal Society B 374 (1772):
20180106.
- Degrazia D (2019). Human-animal chimeras, “human” cognitive
capacities, and moral status. Hastings Center Report 49 (5): 33-
34.
- Doudna JA, Charpentier E (2014). The new frontier of genome
engineering with CRISPR-Cas9. Science 346 (6213): 1258096.
- Duardo-Sanchez A (2017). CRISPR-Cas in medicinal chemistry:
applications and regulatory concerns. Current Topics in
Medicinal Chemistry 17 (30): 3308-3315.
- Duchêne BL, Cherif K, Iyombe-Engembe JP, Guyon A, Rousseau J
et al. (2018). CRISPR-induced deletion with saCas9 restores
dystrophin expression in dystrophic models in vitro and in vivo.
Molecular Therapy 26 (11): 2604-2616.
- Eriksson S, Jonas E, Rydhmer L, Röcklinsberg H (2018). Invited review:
Breeding and ethical perspectives on genetically modified and
genome edited cattle. Journal of Dairy Science 101 (1): 1-17.
- Esvelt KM, Smidler AL, Catteruccia F, Church GM (2014). Concerning
RNA-guided gene drives for the alteration of wild populations.
Elife 3: e03401.
- Firth AL, Menon T, Parker GS, Qualls SJ, Lewis BM et al. 2015.
Functional gene correction for cystic fibrosis in lung epithelial
cells generated from patient iPSCs. Cell Reports 12 (9): 1385-
1390. doi: 10.1016/j.celrep.2015.07.062
- Fung RKF, Kerridge IH (2016). Gene editing advance re-ignites debate
on the merits and risks of animal to human transplantation.
Internal Medicine Journal 46 (9): 1017-1022.
- Gantz VM, Jasinskiene N, Tatarenkova O, Fazekas A, Macias VM
et al. (2015). Highly efficient Cas9-mediated gene drive for
population modification of the malaria vector mosquito
Anopheles stephensi. Proceedings of the National Academy of
Sciences of the USA 112 (49): E6736-E6743.
- Gracheva EO, Ingolia NT, Kelly YM, Cordero-Morales JF, Hollopeter
G et al. (2010). Molecular basis of infrared detection by snakes.
Nature 464 (7291): 1006.
- Greely HT (2019). Human germline genome editing: an assessment.
CRISPR Journal 2 (5): 253-265.
- Greene M, Master Z (2018). Ethical issues of using CRISPR
technologies for research on military enhancement. Journal of
Bioethical Inquiry 15 (3): 327-335.
- Greenfield A (2017). Editing mammalian genomes: ethical
considerations. Mammalian Genome 28 (7-8): 388-393.
- Guo X, Li XJ (2015). Targeted genome editing in primate embryos.
Cell Research 25 (7): 767.
- Halpern J, O’Hara SE, Doxzen KW, Witkowsky LB, Owen AL (2019).
Societal and ethical impacts of germline genome editing: How
can we secure human rights? CRISPR Journal 2 (5): 293-298.
- Hammond A, Galizi R, Kyrou K, Simoni A, Siniscalchi C et al.
(2016). A CRISPR-Cas9 gene drive system targeting female
reproduction in the malaria mosquito vector Anopheles
gambiae. Nature Biotechnology 34 (1): 78.
- Heeger R (2015). Dignity only for humans? A controversy. In: Duwell
M (editor). The Cambridge Handbook of Human Dignity:
Interdisciplinary Perspectives. Cambridge, UK: Cambridge
University Press, pp. 541-545.
- Hermerén G (2015). Ethical considerations in chimera research.
Development 142 (1): 3-5.
- Hirsch F, Iphofen R, Koporc Z (2019). Ethics assessment in research
proposals adopting CRISPR technology. Biochemia Medica 29
(2): 206-213.
- Huisman C, van der Wijst MG, Falahi F, Overkamp J, Karsten G et al.
(2015). Prolonged re-expression of the hypermethylated gene
EPB41L3 using artificial transcription factors and epigenetic
drugs. Epigenetics 10 (5): 384-396.
- Ishii T (2017a). Genome-edited livestock: ethics and social
acceptance. Animal Frontiers 7 (2): 24-32.
- Ishii T (2017b). Germ line genome editing in clinics: the approaches,
objectives and global society. Briefings in Functional Genomics
16 (1): 46-56.
- Kim H, Kim JS (2014). A guide to genome engineering with
programmable nucleases. Nature Reviews Genetics 15 (5):
321-334.
- Kim S, Koo T, Jee HG, Cho HY, Lee G et al. (2018). CRISPR RNAs
trigger innate immune responses in human cells. Genome
Research 28 (3): 367-373.
- Knoppers BM, Kleiderman E (2019). Heritable genome editing: Who
speaks for “future” children? CRISPR Journal 2 (5): 285-292.
- Koo T, Lu-Nguyen NB, Malerba A, Kim E, Kim D et al. (2018).
Functional rescue of dystrophin deficiency in mice caused
by frameshift mutations using campylobacter jejuni Cas9.
Molecular Therapy 26 (6): 1529-1538.
- Koplin JJ (2019). Human-animal chimeras: the moral insignificance
of uniquely human capacities. Hastings Center Report 49 (5):
23-32.
- Lanphier E, Urnov F, Haecker SE, Werner M, Smolenski J (2015).
Don’t edit the human germ line. Nature News 519 (7544): 410.
- Lau RW, Wang B, Ricardo SD (2018). Gene editing of stem cells
for kidney disease modelling and therapeutic intervention.
Nephrology 23 (11): 981-990.
- Lau V, Davie JR (2016). The discovery and development of the
CRISPR system in applications in genome manipulation.
Biochemistry and Cell Biology 95 (2): 203-210.
- Ledford H (2015). CRISPR, the disruptor. Nature 522 (7554): 20-24.
- Li W, Teng F, Li T, Zhou Q (2013). Simultaneous generation and
germline transmission of multiple gene mutations in rat using
CRISPR-Cas systems. Nature Biotechnology 31 (8): 684.
- Liang P, Xu Y, Zhang X, Ding C, Huang R et al. (2015). CRISPR/Cas9-
mediated gene editing in human tripronuclear zygotes. Protein
& Cell 6 (5): 363-372.
- Liao J, Karnik R, Gu H, Ziller MJ, Clement K et al. (2015). Targeted
disruption of DNMT1, DNMT3A and DNMT3B in human
embryonic stem cells. Nature Genetics 47 (5): 469.
- Long C, Li H, Tiburcy M, Rodriguez-Caycedo C, Kyrychenko V et al.
(2018). Correction of diverse muscular dystrophy mutations in
human engineered heart muscle by single-site genome editing.
Science Advances 4 (1): eaap9004.
- Macintosh KL (2019). Heritable genome editing and the downsides
of a global moratorium. CRISPR Journal 2 (5): 272-279.
- Manesh SB, Samani RO, Manesh SB (2014). Ethical issues of
transplanting organs from transgenic animals into human
beings. Cell Journal (Yakhteh) 16 (3): 353.
- Marraffini LA, Sontheimer EJ (2008). CRISPR interference limits
horizontal gene transfer in staphylococci by targeting DNA.
Science 322 (5909): 1843-1845.
- Martinelli L, Oksanen M, Siipi H (2014). De-extinction: a novel
and remarkable case of bio-objectification. Croatian Medical
Journal 55 (4): 423.
- Mei Y, Wang Y, Chen H, Sun ZS, Ju XD (2016). Recent progress in
CRISPR/Cas9 technology. Journal of Genetics and Genomics
43 (2): 63-75.
- Memi F, Ntokou A, Papangeli I (2018). CRISPR/Cas9 gene-editing:
Research technologies, clinical applications and ethical
considerations. Seminars in Perinatology 42 (8): 487-500.
- Mittal RD (2019). Gene editing in clinical practice: where are we?
Indian Journal of Clinical Biochemistry 34 (1): 19-25.
- Neuhaus CP, Zacharias RL (2018). Compassionate use of gene
therapies in pediatrics: an ethical analysis. Seminars in
Perinatology 42 (8): 508-514.
- Niu YY, Shen B, Cui YQ, Chen YC, Wang JY et al. (2014). Generation
of gene-modified cynomolgus monkey via Cas9/RNAmediated gene targeting in one-cell embryos. Cell 156 (4): 836-
843.
- Olson S (editor) (2016). International Summit on Human Gene
Editing: A Global Discussion. Washington, DC, USA: National
Academies Press.
- Ormond KE, Mortlock DP, Scholes DT, Bombard Y, Brody LC et al.
(2017). Human germline genome editing. American Journal of
Human Genetics 101 (2): 167-176.
- Ota S, Hisano Y, Ikawa Y, Kawahara A (2014). Multiple genome
modifications by the CRISPR/Cas9 system in zebrafish. Genes
to Cells 19 (7): 555-564.
- Otieno MO (2015). CRISPR-Cas9 human genome editing: challenges,
ethical concerns and implications. Journal of Clinical Research
and Bioethics 6 (6): 253-255.
- Oye KA, Esvelt K, Appleton E, Catteruccia F, Church G et al. (2014).
Regulating gene drives. Science 345 (6197): 626-628.
- Polcz S, Lewis A (2016). CRISPR-Cas9 and the non-germline noncontroversy. Journal of Law and the Biosciences 3: 413-425. doi:
10.1093/jlb/lsw016
- Ramanan V, Shlomai A, Cox DB, Schwartz RE, Michailidis E et
al. (2015). CRISPR/Cas9 cleavage of viral DNA efficiently
suppresses hepatitis B virus. Scientific Reports 5: 10833.
- Rath D, Amlinger L, Rath A, Lundgren M (2015). The CRISPRCas immune system: biology, mechanisms and applications.
Biochimie 117: 119-128.
- Rodriguez E (2016). Ethical issues in genome editing using Crispr/
Cas9 system. Journal of Clinical Research and Bioethics 7 (2):
266.
- Rodriguez E (2017). Ethical issues in genome editing for non-human
organisms using CRISPR/Cas9 system. Journal of Clinical
Research and Bioethics 8 (300): 10-4172.
- Rodriguez E, Keiser M, McLoughlin H, Zhang F, Davidson BL (2014).
AAV-CRISPR: a new therapeutic approach to nucleotide repeat
diseases. Molecular Therapy 22: 94-94.
- Roh DS, Li EBH, Liao EC (2018). CRISPR Craft: DNA editing the
reconstructive ladder. Plastic and Reconstructive Surgery 142
(5): 1355-1364.
- Rossant J (2018). Gene editing in human development: ethical
concerns and practical applications. Development 145 (16):
dev150888.
- Schultz-Bergin M (2017). The dignity of diminished animals: Species
norms and engineering to improve welfare. Ethical Theory and
Moral Practice 20 (4): 843-856.
- Schultz-Bergin M (2018). Is CRISPR an ethical game changer? Journal
of Agricultural and Environmental Ethics 31 (2): 219-238.
- Senis E, Fatouros C, Große S, Wiedtke E, Niopek D et al. (2014).
CRISPR/Cas9-mediated genome engineering: an adenoassociated viral (AAV) vector toolbox. Biotechnology Journal 9
(11): 1402-1412.
- Sherkow JS (2018). The CRISPR patent landscape: past, present, and
future. CRISPR Journal 1 (1): 5-9.
- Shinwari ZK, Tanveer F, Khalil AT (2017). Ethical issues regarding
CRISPR-mediated genome editing. Current Issues in Molecular
Biology 26: 103-110. doi: 10.21775/9781910190630.09
- Shriver A, McConnachie E (2018). Genetically modifying livestock
for improved welfare: a path forward. Journal of Agricultural
and Environmental Ethics 31 (2): 161-180.
- Swiech L, Heidenreich M, Banerjee A, Habib N, Li Y et al. (2015). In
vivo interrogation of gene function in the mammalian brain
using CRISPR-Cas9. Nature Biotechnology 33 (1): 102.
- Sýkora P (2018). Germline gene therapy in the era of precise genome
editing: how far should we go? In: Soniewicka M (editor). The
Ethics of Reproductive Genetics. Cham, Switzerland: Springer,
pp. 157-171.
- Urnov FD (2018). Genome Editing BC (before CRISPR): lasting
lessons from the “old testament”. CRISPR Journal 1 (1): 34-46.
- van Erp PB, Bloomer G, Wilkinson R, Wiedenheft B (2015). The
history and market impact of CRISPR RNA-guided nucleases.
Current Opinion in Virology 12: 85-90.
- Wang ZP, Xing HL, Dong L, Zhang HY, Han CY et al. (2015). Egg
cell-specific promoter-controlled CRISPR/Cas9 efficiently
generates homozygous mutants for multiple target genes in
Arabidopsis in a single generation. Genome Biology 16 (1):
144.
- Wilson RC, Carroll D (2019). The daunting economics of therapeutic
genome editing. CRISPR Journal 2 (5): 280-284.
- Wu Y, Zhou H, Fan X, Zhang Y, Zhang M et al. (2015). Correction
of a genetic disease by CRISPR-Cas9-mediated gene editing in
mouse spermatogonial stem cells. Cell Research 25 (1): 67.
- Xin L, Min L, Bing S (2016). Application of the genome editing tool
CRISPR/Cas9 in non-human primates. Zoological Research 37
(4): 241.
- Yang A (2015). Thinking Towards the Future of CRISPR/Cas9.
London, UK: Brevia.
- Yang W, Tu Z, Sun Q, Li XJ (2016). CRISPR/Cas9: implications for
modeling and therapy of neurodegenerative diseases. Frontiers
in Molecular Neuroscience 9: (30).
- Yoshimi K, Kaneko T, Voigt B, Mashimo T (2014). Allele-specific
genome editing and correction of disease-associated
phenotypes in rats using the CRISPR–Cas platform. Nature
Communications 5: 4240.
- Yuan M, Gao X, Chard LS, Ali Z, Ahmed J et al. (2015). A markerfree system for highly efficient construction of vaccinia virus
vectors using CRISPR Cas9. Molecular Therapy-Methods &
Clinical Development 2: 15035.
- Yumlu S, Bashir S, Stumm J, Kühn R (2019). Efficient gene editing
of human induced pluripotent stem cells using CRISPR/Cas9.
In: Luo Y (editor). CRISPR Gene Editing. New York, NY, USA:
Humana Press, pp. 137-151.
- Zhang F, Wen Y, Guo X (2014). CRISPR/Cas9 for genome editing:
progress, implications and challenges. Human Molecular
Genetics 23 (1): 40-46.
- Zhang XL, Wei P, Xin-Tian H, Jia-Li L, Yong-Gang Y et al. (2014).
Experimental primates and non-human primate (NHP)
models of human diseases in China: current status and
progress. Zoological Research 35 (6): 447.
- Zou Q, Wang X, Liu Y, Ouyang Z, Long H et al. (2015). Generation
of gene-target dogs using CRISPR/Cas9 system. Journal of
Molecular Cell Biology 7 (6): 580-583.